Physician profile
Roy Chung
NPI 1134320963
$18,926.88
in general payments reported to CMS, 2019-2025
12 companies · $1,914 in 2025
The $1,914 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,976 · 2020: $28.51 · 2021: $3,073 · 2022: $517 · 2023: $3,062 · 2024: $3,356 · 2025: $1,914.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,542 · Consulting Fee: $2,249 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,100 · Travel and Lodging: $1,441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,541.76 |
| Consulting Fee | $2,249.10 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,100.00 |
| Travel and Lodging | $1,440.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $9,522.07 | 2019-2024 | Carto 3 |
| Medtronic, INC. | $3,702.89 | 2021-2025 | Micra, Arctic Front Advance, Selectsecure |
| Medical Device Business Services, INC. | $1,996.71 | 2021-2024 | Carto 3 |
| Abbott Laboratories | $1,628.67 | 2022-2025 | Ensite, Ensite Precision, Na |
| Medtronic Vascular, INC. | $1,557.76 | 2019 | |
| Boston Scientific Corporation | $427.95 | 2019-2025 | General - Therapies |
| Cardiva Medical, INC. | $23.27 | 2019 | |
| Teleflex LLC | $17.25 | 2024 | Guideliner |
| Preventice Services, LLC | $15.57 | 2021 | |
| Pfizer INC. | $12.28 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.67 | 2019 | |
| Cvrx, INC. | $10.79 | 2025 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Chung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.